SCHEMBL7669530

SCHEMBL7669530

O=Cc1cc(C(=O)O)cc(O)c1O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.64
▸ ALDH1A1 P00352 2/20 0.64
▸ KDM4E B2RXH2 2/20 0.64
▸ CA12 O43570 2/20 0.64
▸ CA1 P00915 2/20 0.64
▸ CA2 P00918 2/20 0.64
▸ CA4 P22748 2/20 0.64
▸ CA6 P23280 2/20 0.64
▸ CA7 P43166 2/20 0.64
▸ CA9 Q16790 2/20 0.64
▸ CA14 Q9ULX7 2/20 0.64
▸ LMNA P02545 1/20 0.64
▸ TP53 P04637 1/20 0.64
▸ CA3 P07451 1/20 0.64
▸ SELL P14151 1/20 0.64
▸ HPGD P15428 1/20 0.64
▸ SELP P16109 1/20 0.64
▸ FUT4 P22083 1/20 0.64
▸ DPP4 P27487 1/20 0.64
▸ MAPK1 P28482 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12491809 0.89 ERN1 (0.54) MAPTALDH1A1KDM4ECA12CA1
SCHEMBL29475526 0.84 ERN1 (0.66) MAPTALDH1A1KDM4ECA12CA1
SCHEMBL22465969 0.84 ERN1 (0.66) MAPTALDH1A1KDM4ECA12CA1
SCHEMBL21579476 0.82 CA12 (0.61) MAPTALDH1A1KDM4ECA12CA1
Gallic Acid SCHEMBL27698025 0.80 CA12 (0.81) MAPTALDH1A1KDM4ECA12CA1
SCHEMBL25385602 0.80 TTR (0.67) MAPTALDH1A1KDM4ECA12CA1
SCHEMBL30574966 0.80 TTR (0.67) MAPTALDH1A1KDM4ECA12CA1
SCHEMBL5648278 0.80 ERN1 (0.50) MAPTALDH1A1KDM4ECA12CA1
SCHEMBL31056230 0.80 TTR (0.67) MAPTALDH1A1KDM4ECA12CA1
Gallic Acid SCHEMBL1845406 0.79 CA12 (1.00) MAPTALDH1A1KDM4ECA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6380181-B1 AMINO ACID RESIDUES IN THE 3-AND/OR 4-POSITION FUNCTION AS SIDEROPHORES AND/OR AS BIOLOGICAL CHELATING AGENTS FOR IRON IN GRAM-NEGATIVE BACTERIA GRUENENTHAL GMBH (DE) 2002-04-30 — — US disclosed
EP-0907633-B1 NEW SYNTHETIC CATECHOL DERIVATIVES, METHOD FOR PRODUCTION AND USE THEREOF GRUENENTHAL GMBH (DE) 2001-08-22 — — EP disclosed
EP-0907633-A1 NEW SYNTHETIC CATECHOL DERIVATIVES, METHOD FOR PRODUCTION AND USE THEREOF Grünenthal GmbH (DE) 1999-04-14 — — EP disclosed
EP-0584085-B1 ANTIBIOTIC CARBAPENEM DERIVATIVES ZENECA LTD (GB) 1998-09-09 — — EP disclosed
WO-1997049670-A1 NEW SYNTHETIC CATECHOL DERIVATIVES, METHOD FOR PRODUCTION AND USE THEREOF Grünenthal GmbH (DE) 1997-12-31 — — WO disclosed
US-5554606-A THIENAMYCIN DERIVATIVES; PSEUDOMONAS ZENECA LIMITED (GB) 1996-09-10 — — US disclosed
EP-0584085-A1 ANTIBIOTIC CARBAPENEM DERIVATIVES ZENECA LIMITED (GB) 1994-03-02 — — EP disclosed
WO-1992017479-A1 ANTIBIOTIC CARBAPENEM DERIVATIVES ZENECA LTD. (GB) 1992-10-15 — — WO disclosed
US-5126444-A Antibiotics IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-06-30 — — US disclosed
US-5064824-A CEPHALOSPORIN COMPOUNDS IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1991-11-12 — — US disclosed
EP-0341910-A2 Cephalosporins, process for their preparation, intermediates and pharmaceutical compositions ZENECA LIMITED (GB) 1989-11-15 — — EP disclosed
Send feedback